FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Jill Kolesar

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Physiology

Genotype

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Giangthy N Ton; Megan E Banaszynski; Jill M Kolesar
Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer.
Yang Zhang; Lee C Vermeulen; Jill M Kolesar
Stability of stock and diluted rituximab.
Ho-Chul Shin; Tsz Chung Lai; Hyunah Cho; Jill M Kolesar; Kevin R Kozak; Glen S Kwon
Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Jill Kolesar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Giangthy N Ton; Megan E Banaszynski; Jill M Kolesar
Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(10):849-55.
2013: Yang Zhang; Lee C Vermeulen; Jill M Kolesar
Stability of stock and diluted rituximab.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(5):436-8.
2012: Ho-Chul Shin; Tsz Chung Lai; Hyunah Cho; Jill M Kolesar; Kevin R Kozak; Glen S Kwon
Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Journal of controlled release : official journal of the Controlled Release Society 2012;163(1):93-9.
2012: Rachel Pearson; Jill M Kolesar
Targeted therapy for NSCLC: ALK inhibition.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2012;18(2):271-4.
2012: Kimberly J Gorden; Parvin Mesbah; Jill M Kolesar
EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2012;18(2):245-9.
2012: Edward Messing; Howard Parnes; Daniel R Saltzstein; Joseph Tangrea; Marcia A Wheeler; Jay M Young; J Erik Busby; Anthony diSant'Agnese; Mitchell Efros; Adrienne Faerber; Jason R Gee; Robert H Getzenberg; Linda Harris; Thomas C Havighurst; Raymond Hohl; Margaret House; KyungMann Kim; Jill M Kolesar; Howard Bailey
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Cancer prevention research (Philadelphia, Pa.) 2012;5(4):621-30.
2011: Joshua P Vanderloo; Lee C Vermeulen; Marcia L Pomplun; Jill M Kolesar
Stability of unused reconstituted bortezomib in original manufacturer vials.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2011;17(4):400-2.
2011: Yang Zhang; Jill M Kolesar
Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura.
Clinical therapeutics 2011;33(11):1560-76.
2011: Jill M Kolesar; Suzanne E Dahlberg; Sharon Marsh; Howard L McLeod; David H Johnson; Steven M Keller; Joan H Schiller
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.
Oncology reports 2011;25(6):1765-72.
2011: Jill M Kolesar; Richard C Brundage; Marcia Pomplun; Dona Alberti; Kyle Holen; Anne Traynor; Percy Ivy; George Wilding
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients.
Cancer chemotherapy and pharmacology 2011;67(2):393-400.
2010: Jill M Kolesar; Ryan Hoel; Marcia Pomplun; Thomas C Havighurst; Jeanne Stublaski; Barbara Wollmer; Helen Krontiras; Wayne Brouillette; Donald Muccio; KyungMann Kim; Clinton J Grubbs; Howard E Bailey
A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteers.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1565-70.
2010: Joseph Bonkowski; Lee C Vermeulen; Jill M Kolesar
The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2010;16(4):223-32.
2010: Ryuji Ikeda; Lee C Vermeulen; Elim Lau; Zhisheng Jiang; Marcia Pomplun; Jill M Kolesar
Establishment and characterization of irinotecan-resistant human non-small cell lung cancer A549 cells.
Molecular medicine reports 2010;3(6):1031-4.
2010: Jens C Eickhoff; KyungMann Kim; Jason Beach; Jill M Kolesar; Jason R Gee
A Bayesian adaptive design with biomarkers for targeted therapies.
Clinical trials (London, England) 2010;7(5):546-56.
2010: Brian S Choi; Dona Alberti; William R Schelman; Jill M Kolesar; James P Thomas; Rebecca Marnocha; Jens Eickhoff; S Percy Ivy; George Wilding; Kyle D Holen
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
Cancer chemotherapy and pharmacology 2010;66(5):973-80.
2010: Shannon M Kavanaugh; Shannon A Kavanaugh; Lisa A White; Jill M Kolesar
Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2010;67(10):793-7.
2010: Alma Hamidovic; Kristine Hahn; Jill M Kolesar
Clinical significance of ABCB1 genotyping in oncology.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2010;16(1):39-44.
2010: Anne M Traynor; Ju-Whei Lee; Gerald K Bayer; John M Tate; Sachdev P Thomas; Miroslaw Mazurczak; David Graham; Jill M Kolesar; Joan H Schiller
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Investigational new drugs 2010;28(1):91-7.
2009: Erin E Mancl; Jill M Kolesar; Lee C Vermeulen
Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2009;66(23):2105-12.
2009: Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill M Kolesar; Musie Ghebremichael; Michael Pins; Kristine Hahn; Rita Axelrod; Arlene A Forastiere
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.
Cancer 2009;115(19):4504-13.
2009: Daniel Mulkerin; N K LoConte; K D Holen; James P Thomas; Dona Alberti; Rebecca Marnocha; Jill M Kolesar; Jens Eickhoff; K Oliver; Chris Feierabend; George Wilding
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
Investigational new drugs 2009;27(5):461-8.
2009: Jill M Kolesar; Wei Huang; Jens Eickhoff; Kristine Hahn; Dona Alberti; Steven Attia; William R Schelman; Kyle Holen; Anne Traynor; Percy Ivy; George Wilding
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
Cancer chemotherapy and pharmacology 2009;64(1):79-86.
2009: William R Schelman; Sherry Morgan-Meadows; Rebecca Marnocha; Fred Lee; Jens Eickhoff; Wei Huang; Marcia Pomplun; Zhisheng Jiang; Dona Alberti; Jill M Kolesar; Percy Ivy; George Wilding; Anne M Traynor
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;63(6):1147-56.
2009: Y Xu; Jill M Kolesar; Larry J Schaaf; R Drengler; Wenrui Duan; Gregory A Otterson; C Shapiro; John Kuhn; Miguel A Villalona-Calero
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
Cancer chemotherapy and pharmacology 2009;63(6):1073-82.
2009: Anne M Traynor; Sarita Dubey; Jens C Eickhoff; Jill M Kolesar; Kathleen Schell; Michael S Huie; David L Groteluschen; Sarah M Marcotte; Courtney M Hallahan; Hilary R Weeks; George Wilding; Igor Espinoza-Delgado; Joan H Schiller
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(4):522-6.
2009: Anne M Traynor; Joan H Schiller; Laura P Stabile; Jill M Kolesar; Jens C Eickhoff; Sanja Dacic; Tien Hoang; Sarita Dubey; Sarah M Marcotte; Jill M Siegfried
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;64(1):51-9.
2009: Amye J Tevaarwerk; Jill M Kolesar
Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer.
Clinical therapeutics 2009;31 Pt 2():2332-48.
2009: Trevor W Dennie; Jill M Kolesar
Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Clinical therapeutics 2009;31 Pt 2():2290-311.
2008: Annelise Thomsen; Jill M Kolesar
Chemoprevention of breast cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008;65(23):2221-8.
2008: Noelle K LoConte; James P Thomas; Dona Alberti; Jennifer Heideman; Kim Binger; Rebecca Marnocha; Kyle Utecht; Peter Geiger; Jens Eickhoff; George Wilding; Jill M Kolesar
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2008;63(1):109-15.
2008: Steven Attia; Jill M Kolesar; Michelle R Mahoney; Henry C Pitot; Daniel Laheru; James Heun; Wei Huang; Jens Eickhoff; Charles Erlichman; Kyle D Holen
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
Investigational new drugs 2008;26(4):369-79.
2008: Glenn Liu; Jill M Kolesar; Douglas G McNeel; Catherine Leith; K Schell; Jens Eickhoff; Fred Lee; Anne Traynor; Rebecca Marnocha; Dona Alberti; James Zwiebel; George Wilding
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2732-9.
2008: Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
Journal of inorganic biochemistry 2008;102(4):693-8.
2008: Mike J Hallam; Jill M Kolesar
Hydroxyurea induced acute elevations in liver function tests.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2008;14(1):61-3.
2008: Jon J Hiles; Jill M Kolesar
Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008;65(2):123-31.
2008: Elizabeth Dobbe; Kristen Gurney; Sara Kiekow; Jeffery S Lafferty; Jill M Kolesar
Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008;65(1):23-8.
2007: Marcia Pomplun; Jeremy James Johnson; Susan Johnston; Jill M Kolesar
Stability of a heparin-free 50% ethanol lock solution for central venous catheters.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2007;13(1):33-7.
2006: Kyle N Utecht; Jon J Hiles; Jill M Kolesar
Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(23):2340-8.
2006: Kristine K Hahn; James J Wolff; Jill M Kolesar
Pharmacogenetics and irinotecan therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(22):2211-7.
2006: Susan C Fagan; Daniel Touchette; Judith A Smith; Kevin M Sowinski; Lisa Dolovich; Kari L Olson; Kai I Cheang; Jill M Kolesar; M Lynn Crismon
The state of science and research in clinical pharmacy.
Pharmacotherapy 2006;26(7):1027-40.
2006: Sarita Dubey; Patricia Stephenson; Donna E Levy; Judith A Miller; Steven M Keller; Joan H Schiller; David H Johnson; Jill M Kolesar
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):406-12.
2006: Katie L Kabe; Jill M Kolesar
Role of trastuzumab in adjuvant therapy for locally invasive breast cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(6):527-33.
2006: Athanassios Argiris; Thomas A Hensing; Anjana V Yeldandi; Smita Patel; Adekunle Raji; Charles Sturgis; Gregory Masters; William Gooding; Michael Pins; Jill M Kolesar
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(1):52-60.
2005: Douglas G McNeel; Jens Eickhoff; Fred T Lee; David M King; Dona Alberti; James P Thomas; Andreas Friedl; Jill M Kolesar; Rebecca Marnocha; Jennifer Volkman; Jianliang Zhang; Luz D Hammershaimb; James A Zwiebel; George Wilding
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7851-60.
2005: Christopher Sweeney; Glenn Liu; Constantin T Yiannoutsos; Jill M Kolesar; Dorothea Horvath; Mary Jane Staab; Karen Fife; Victoria Armstrong; Anthony Treston; Carolyn Sidor; George Wilding
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6625-33.
2005: Michelle L Radtke; Jill M Kolesar
Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2005;11(3):121-5.
2005: Meaghan Sullivan; Kristine Hahn; Jill M Kolesar
Azacitidine: a novel agent for myelodysplastic syndromes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(15):1567-73.
2005: Lindsey Wilhelm; Jill M Kolesar
Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(13):1365-9.
2005: Jill M Kolesar
Bevacizumab: improved survival at what cost?
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(10):1017.
2004: Lynn Van Ummersen; Kim Binger; Jennifer Volkman; Rebecca Marnocha; Kendra Tutsch; Jill M Kolesar; Rhoda Arzoomanian; Dona Alberti; George Wilding
A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7450-6.
2002: Jill M Kolesar; Stuart C Pritchard; Keith M Kerr; Kyungman Kim; Marianne C Nicolson; howard mcleod
Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue.
International journal of oncology 2002;21(5):1119-24.
2002: Miguel A Villalona-Calero; Jill M Kolesar
Mitomycin as a modulator of irinotecan anticancer activity.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):21-5.
2002: Jill M Kolesar
Novel approaches to anemia associated with cancer and chemotherapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(15 Suppl 4):S8-11.
2002: Peter G Allen; Jill M Kolesar
NAD(P)H: quinone oxidoreductase enhances proliferation inhibition by 4-hydroxytamoxifen.
Anticancer research 2002;22(3):1475-80.
2002: Sherry Morgan Meadows; Daniel Mulkerin; Jordan Berlin; Howard H Bailey; Jill M Kolesar; Deb Warren; James P Thomas
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer.
International journal of gastrointestinal cancer 2002;32(2-3):125-8.
2001: Nikhil V Dhurandhar; Barbara A Israel; Jill M Kolesar; G Mayhew; Mark E Cook; Richard L Atkinson
Transmissibility of adenovirus-induced adiposity in a chicken model.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(7):990-6.
2000: Nikhil V Dhurandhar; Barbara A Israel; Jill M Kolesar; G F Mayhew; Mark E Cook; Richard L Atkinson
Increased adiposity in animals due to a human virus.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(8):989-96.
2000: Jill M Kolesar; J A Miller; Nikhil V Dhurandhar; Richard L Atkinson
Direct quantification of AD-36 adenovirus DNA by capillary electrophoresis with laser-induced fluorescence.
Journal of chromatography. B, Biomedical sciences and applications 2000;744(1):1-8.
1999: Jill M Kolesar; C L Johnson; B L Freeberg; J D Berlin; J H Schiller
Warfarin-5-FU interaction--a consecutive case series.
Pharmacotherapy 1999;19(12):1445-9.
1999: S A Kinikar; Jill M Kolesar
Identification of a gemcitabine-warfarin interaction.
Pharmacotherapy 1999;19(11):1331-3.
1997: Jill M Kolesar; P G Allen; C M Doran
Direct quantification of HIV-1 RNA by capillary electrophoresis with laser-induced fluorescence.
Journal of chromatography. B, Biomedical sciences and applications 1997;697(1-2):189-94.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.